147 related items for PubMed ID: 12762348
21. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA, Asthma Clinical Research Network of the National Heart Lung, and Blood Institute.
J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
[Abstract] [Full Text] [Related]
22. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
Wilson AM, McFarlane LC, Lipworth BJ.
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
[Abstract] [Full Text] [Related]
23. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM, Clark DJ, McFarlane L, Lipworth BJ.
Eur J Clin Pharmacol; 1997 Oct; 53(1):33-7. PubMed ID: 9349927
[Abstract] [Full Text] [Related]
24. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
Muley P, Shah M, Muley A.
Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
[Abstract] [Full Text] [Related]
25. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
26. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
Wolfe J, Rooklin A, Grady J, Munk ZM, Stevens A, Prillaman B, Duke S, Harding S.
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
[Abstract] [Full Text] [Related]
27. Inhaled fluticasone in asthmatic children.
Pescollderungg L, Radetti G, Gottardi E, Gentili L, Pietrobelli A, Boner AL.
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):328-9; author reply 329. PubMed ID: 12269658
[No Abstract] [Full Text] [Related]
28. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[Abstract] [Full Text] [Related]
29. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
[Abstract] [Full Text] [Related]
30. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
31. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[Abstract] [Full Text] [Related]
32. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.
Li JT, Goldstein MF, Gross GN, Noonan MJ, Weisberg S, Edwards L, Reed KD, Rogenes PR.
J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011
[Abstract] [Full Text] [Related]
33. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
Clark DJ, Clark RA, Lipworth BJ.
Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
[Abstract] [Full Text] [Related]
34. Adrenal function and high dose inhaled corticosteroids for asthma.
Yiallouros PK, Milner AD, Conway E, Honour JW.
Arch Dis Child; 1997 May; 76(5):405-10. PubMed ID: 9196354
[Abstract] [Full Text] [Related]
35. Early morning salivary cortisol and cortisone, and adrenal responses to a simplified low-dose short Synacthen test in children with asthma.
Blair J, Lancaster G, Titman A, Peak M, Newlands P, Collingwood C, Chesters C, Moorcroft T, Wallin N, Hawcutt D, Gardner C, Didi M, Lacy D, Couriel J.
Clin Endocrinol (Oxf); 2014 Mar; 80(3):376-83. PubMed ID: 23895277
[Abstract] [Full Text] [Related]
36. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children.
Priftis KN, Papadimitriou A, Gatsopoulou E, Yiallouros PK, Fretzayas A, Nicolaidou P.
Eur Respir J; 2006 Feb; 27(2):316-20. PubMed ID: 16452586
[Abstract] [Full Text] [Related]
37. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
Pedersen S, Engelstätter R, Weber HJ, Hirsch S, Barkai L, Emeryk A, Weber H, Vermeulen J.
Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
[Abstract] [Full Text] [Related]
38. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Lönnebo A, Johansson M, Eckernäs SA.
Eur J Clin Pharmacol; 1997 Jun; 52(4):261-7. PubMed ID: 9248762
[Abstract] [Full Text] [Related]
39. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
40. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.
Bisgaard H, Allen DB, Milanowski J, Kalev I, Willits L, Davies P.
Pediatrics; 2004 Feb; 113(2):e87-94. PubMed ID: 14754977
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
